TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26341548

Group type: EXPERIMENTAL
Intervention: Inhalation of 400 μg salbutamol in standard posture
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Inhalation of 200 μg salbutamol in standard posture
Number of subjects: 22

Group type: COMPARATOR
Intervention: Inhalation of salbutamol in forward leaning posture
Number of subjects: 22
Study: 23910574

Group type: EXPERIMENTAL
Intervention: Pramipexole
Number of subjects: 0
Study: 20713345

Group type: EXPERIMENTAL
Intervention: Biphasic insulin aspart 70/30 (BIAsp 30) + metformin
Number of subjects: 280

Group type: COMPARATOR
Intervention: Insulin glargine + metformin + secretagogues
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Biphasic insulin aspart 70/30 (BIAsp 30)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 280
Study: 19050653

Group type: EXPERIMENTAL
Intervention: Manual Resistance Training (MRT)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Weight Resistance Training (WRT)
Number of subjects: 84
Study: 17098140

Group type: EXPERIMENTAL
Intervention: 3-dimensional echocardiography
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 3-dimensional echocardiography adjusted to lean body mass
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Doppler tissue imaging (DTI)
Number of subjects: 54
Study: 15258475

Group type: EXPERIMENTAL
Intervention: Patients' reports
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Providers' reports
Number of subjects: 179
Study: 14733417

Group type: EXPERIMENTAL
Intervention: Intravenous ascorbic acid (AA) 200 mg 3 times/week
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Low-dose desferroxamine (DFO) 1 mg/Kg/week
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 27
Study: 10836600

Group type: EXPERIMENTAL
Intervention: Sonographically guided air-enema reduction
Number of subjects: 199

Group type: COMPARATOR
Intervention: Fluoroscopically guided air reduction
Number of subjects: 199
Study: 9168506

Group type: EXPERIMENTAL
Intervention: Intensive three-step protocol consisting of colistin inhalations and oral ciprofloxacin.
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group (historic controls).
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Aggressive treatment (intensive protocol).
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Treated patients who developed chronic PA infection.
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: High-dose treatment with colistin inhalation and oral ciprofloxacin for 3 months.
Number of subjects: 91
Study: 1541782

Group type: EXPERIMENTAL
Intervention: Carbamide peroxide tooth whitening products
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo agent
Number of subjects: 0
Study: 3541428

Group type: EXPERIMENTAL
Intervention: Purified chick embryo cell vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Purified Vero rabies vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fetal bovine kidney cell vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: HDCV (commercial human diploid cell vaccine)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2-1-1 postexposure regimen (all vaccines)
Number of subjects: 0
Study: 28439774

Group type: EXPERIMENTAL
Intervention: High-dose intravenous (IV) albumin infusion (n=100)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: High-dose intravenous (IV) albumin infusion within 2 hours of onset
Number of subjects: 189

Group type: COMPARATOR
Intervention: Placebo (n=89)
Number of subjects: 189
Study: 26821621

Group type: EXPERIMENTAL
Intervention: ezetimibe/simvastatin
Number of subjects: 18144
Study: 24582900

Group type: EXPERIMENTAL
Intervention: Handball training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 22814302

Group type: EXPERIMENTAL
Intervention: Integuseal (cyanoacrylate microbial sealant)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Not using Integuseal (control group)
Number of subjects: 56
Study: 21176630

Group type: EXPERIMENTAL
Intervention: Cypher Select stent
Number of subjects: 228

Group type: COMPARATOR
Intervention: Excel stent
Number of subjects: 228
Study: 18250260

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nocebo
Number of subjects: 20
Study: 16402634

Group type: EXPERIMENTAL
Intervention: D-003 (10 mg/day)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 12562581

Group type: EXPERIMENTAL
Intervention: Tandospirone (5-HT(1A) agonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no specific control mentioned)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tandospirone
Number of subjects: 0
Study: 10357321

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium (5.4 mmol)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 39
Study: 8951447

Group type: EXPERIMENTAL
Intervention: Tympanometric preconditioning at 50 daPa/s
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Tympanometric preconditioning at 100 daPa/s
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Tympanometric preconditioning at 200 daPa/s
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Tympanometric preconditioning at 400 daPa/s
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: All rates of tympanometric preconditioning
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: High compliance tympanic membranes
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: 5 tympanometries
Number of subjects: 103
Study: 1756347

Group type: EXPERIMENTAL
Intervention: Anti-anxiety drug
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Antidepressant
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144

Group type: COMPARATOR
Intervention: Counselling
Number of subjects: 144
Study: 6800536

Group type: EXPERIMENTAL
Intervention: Endoscopy
Number of subjects: 1037

Group type: COMPARATOR
Intervention: Barium radiography
Number of subjects: 1037
Study: 30727980

Group type: EXPERIMENTAL
Intervention: RGB-02
Number of subjects: 239

Group type: COMPARATOR
Intervention: Reference pegfilgrastim (Neulasta®)
Number of subjects: 239
Study: 28846688

Group type: EXPERIMENTAL
Intervention: Pregnancy Outreach Worker (POW) intervention
Number of subjects: 486

Group type: COMPARATOR
Intervention: Standard maternity care
Number of subjects: 486
Study: 26475420

Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone (DEX) 5 mg/d
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo therapy (intravenous normal saline)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both DEX and placebo treatments
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Presence of spontaneous nystagmus (SPN)
Number of subjects: 26
Study: 23244565

Group type: EXPERIMENTAL
Intervention: Physical activity intervention with spiritual strategies
Number of subjects: 27
Study: 21309844

Group type: EXPERIMENTAL
Intervention: Candesartan 32 mg daily
Number of subjects: 1973

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1973
Study: 19166566

Group type: EXPERIMENTAL
Intervention: Ever having had a mammogram
Number of subjects: 537

Group type: EXPERIMENTAL
Intervention: Mammography use within the past 2 years
Number of subjects: 537
Study: 16761235

Group type: EXPERIMENTAL
Intervention: Topical ofloxacin (0.3%) four times a day for 3 days
Number of subjects: 159

Group type: COMPARATOR
Intervention: Control group (no antibiotic)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Topical ofloxacin (0.3%)
Number of subjects: 159
Study: 15101564

Group type: EXPERIMENTAL
Intervention: Ziprasidone i.m. 5 mg qid
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Ziprasidone i.m. 10 mg qid
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Ziprasidone i.m. 20 mg qid
Number of subjects: 306

Group type: COMPARATOR
Intervention: Haloperidol i.m. up to 10 mg bid-qid
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Transition to oral ziprasidone
Number of subjects: 306
Study: 12269867

Group type: EXPERIMENTAL
Intervention: PBL cases formatted in short segments
Number of subjects: 74

Group type: COMPARATOR
Intervention: PBL cases formatted in long segments
Number of subjects: 74
Study: 9845401

Group type: EXPERIMENTAL
Intervention: Ranitidine bismuth citrate 400 mg b.d. and clarithromycin 500 mg b.d. for 2 weeks (RC)
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Ranitidine bismuth citrate 400 mg b.d., clarithromycin 500 mg b.d. and metronidazole 400 mg b.d. for 1 week (RCM)
Number of subjects: 350
Study: 8136565

Group type: EXPERIMENTAL
Intervention: CsA+azathioprine (Aza)+prednisone (TD)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Aza+prednisone (CsA D/C)
Number of subjects: 92
Study: 2808259

Group type: EXPERIMENTAL
Intervention: More extensive treatment experimental group
Number of subjects: 96

Group type: COMPARATOR
Intervention: Minimal treatment control group
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 96
Study: 1108582

Group type: EXPERIMENTAL
Intervention: bupivacaine 0.5% with adrenaline 5 mug/ml
Number of subjects: 40

Group type: COMPARATOR
Intervention: etidocaine 1.0% with adrenaline 5 mug/ml
Number of subjects: 40
Study: 7358235

Group type: EXPERIMENTAL
Intervention: Supplementary food
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (non-supplemented mothers)
Number of subjects: 0
Study: 31596897

Group type: EXPERIMENTAL
Intervention: Breastfeeding information received by mothers
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Higher average household income per year
Number of subjects: 417
Study: 29212350

Group type: EXPERIMENTAL
Intervention: Low ecological memory training
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: High ecological memory training
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Low ecological reasoning training
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: High ecological reasoning training
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 86
Study: 26880476

Group type: EXPERIMENTAL
Intervention: Internet-based Climate Schools: Ecstasy and Emerging Drugs module delivered once weekly for 4 weeks during health education classes.
Number of subjects: 1126

Group type: COMPARATOR
Intervention: Control group received health education as usual.
Number of subjects: 1126

Group type: EXPERIMENTAL
Intervention: Internet-based Climate Schools: Ecstasy and Emerging Drugs module.
Number of subjects: 1126
Study: 24699072

Group type: EXPERIMENTAL
Intervention: Temporary cART during primary HIV-infection
Number of subjects: 0
Study: 22272935

Group type: EXPERIMENTAL
Intervention: Specialized health coaching (HC) intervention
Number of subjects: 220

Group type: COMPARATOR
Intervention: Education Alone
Number of subjects: 220
Study: 19758428

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention including individual motivational interviewing aimed at weight reduction, increase in physical activity, fibre and carbohydrate intake, and reduction of fat intake
Number of subjects: 102

Group type: COMPARATOR
Intervention: Usual care Control
Number of subjects: 102
Study: 18341810

Group type: EXPERIMENTAL
Intervention: Pacemaker syndrome (PMS) group
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Without pacemaker syndrome (PMS) group
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: PMS group
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Without PMS group
Number of subjects: 48
Study: 12847157

Group type: EXPERIMENTAL
Intervention: Migraine sufferers
Number of subjects: 45
Study: 11783328

Group type: EXPERIMENTAL
Intervention: XMT plus western medicine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Western medicine alone
Number of subjects: 60
Study: 9195237

Group type: EXPERIMENTAL
Intervention: Side by side catheter
Number of subjects: 55

Group type: COMPARATOR
Intervention: Coaxial catheter
Number of subjects: 55
Study: 8482181

Group type: COMPARATOR
Intervention: Defecation upon urge
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Voluntary suppression of defecation
Number of subjects: 12
Study: 3514366

Group type: EXPERIMENTAL
Intervention: Intravaginal application of tablets containing PGE2
Number of subjects: 345

Group type: COMPARATOR
Intervention: Spontaneous onset of labour
Number of subjects: 345
Study: 31852811

Group type: COMPARATOR
Intervention: mFOLFOX6 (Arm A)
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: mFOLFOX6 with bevacizumab (Arm B)
Number of subjects: 355
Study: 28319423

Group type: EXPERIMENTAL
Intervention: Silexan 80 mg/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Silexan 160 mg/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg/d
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25431431

Group type: EXPERIMENTAL
Intervention: 123I-FP-CIT SPECT scan (DaTSCAN™)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Control group (no scan)
Number of subjects: 187
Study: 23676774

Group type: EXPERIMENTAL
Intervention: Kinesio Tape (KT) applied postoperatively for 5 days
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no KT application)
Number of subjects: 26
Study: 21301812

Group type: EXPERIMENTAL
Intervention: 40 mg hydrocortisone
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 20 mg hydrocortisone
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 19432828

Group type: EXPERIMENTAL
Intervention: Longer duration of exclusive breastfeeding
Number of subjects: 2094

Group type: EXPERIMENTAL
Intervention: Thymic index (TI) at birth and at 8 weeks
Number of subjects: 2094

Group type: EXPERIMENTAL
Intervention: Thymic size
Number of subjects: 2094
Study: 17540227

Group type: EXPERIMENTAL
Intervention: Behavioral inpatient treatment
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Psychodynamic inpatient treatment
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Overall treatment (both types)
Number of subjects: 267
Study: 15040538

Group type: EXPERIMENTAL
Intervention: 4 mg/day of recombinant human growth hormone (rhGH) for 12 weeks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo, alternate day or twice weekly dosing of rhGH
Number of subjects: 12
Study: 11554425

Group type: COMPARATOR
Intervention: Carbamazepine combined with placebo for 21 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carbamazepine combined with mirtazapine for 7 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mirtazapine combined with placebo for 7 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mirtazapine combined with carbamazepine for 21 days
Number of subjects: 0
Study: 9385024

Group type: EXPERIMENTAL
Intervention: Telephone interview
Number of subjects: 28
Study: 7956582

Group type: EXPERIMENTAL
Intervention: Combined anorectal procedures with lateral internal sphincterotomy
Number of subjects: 57

Group type: COMPARATOR
Intervention: Lateral internal sphincterotomy alone (control group)
Number of subjects: 57
Study: 3630804

Group type: EXPERIMENTAL
Intervention: Nicotine fading
Number of subjects: 28

Group type: COMPARATOR
Intervention: Maintenance condition (includes behavioral contracting and extended treatment)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Maintenance condition
Number of subjects: 28
Study: 31285069

Group type: EXPERIMENTAL
Intervention: Daily exercise program for 30 days, once a day for 7-10 minutes.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 24
Study: 31546969

Group type: EXPERIMENTAL
Intervention: HMB supplementation
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study: 28951402

Group type: EXPERIMENTAL
Intervention: Health equity-relevant randomised trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-health equity relevant trials
Number of subjects: 0
Study: 26169952

Group type: EXPERIMENTAL
Intervention: Real-time video consultation
Number of subjects: 31

Group type: COMPARATOR
Intervention: Traditional in-person consultation
Number of subjects: 31
Study: 23419385

Group type: EXPERIMENTAL
Intervention: Midodrine plus standard medical therapy (SMT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Clonidine plus SMT
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combination of midodrine and clonidine plus SMT
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clonidine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard medical therapy (SMT)
Number of subjects: 60
Study: 21627522

Group type: EXPERIMENTAL
Intervention: Methadone IV (0.3 mg/kg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Methadone OTM (0.6 mg/kg)
Number of subjects: 8
Study: 19338551

Group type: EXPERIMENTAL
Intervention: Prolonged sacral neuromodulation testing
Number of subjects: 20
Study: 16772446

Group type: EXPERIMENTAL
Intervention: Green Tea (GT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Black Tea (BT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Caffeine-matched soda control (SC)
Number of subjects: 20
Study: 15041578

Group type: COMPARATOR
Intervention: 0.8 mL/kg of plain local anesthetic mixture (lidocaine 1% + bupivacaine 0.25% (50/50) + 1 microg/mL of fentanyl)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 1 mL/kg of the same mixture with 5 microg/mL of adrenaline
Number of subjects: 48
Study: 11348933

Group type: EXPERIMENTAL
Intervention: Short-acting beta(2)-agonist (SA), n = 48
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Long-acting beta(2)-agonist (LA), n = 50
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo, n = 47
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: All groups (SA, LA, Placebo)
Number of subjects: 145
Study: 9554298

Group type: EXPERIMENTAL
Intervention: Topical cyproterone acetate lotion (20 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo lotion
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Oral cyproterone acetate (2 mg) and ethinyl estradiol (0.035 mg)
Number of subjects: 40
Study: 8061854

Group type: EXPERIMENTAL
Intervention: Spirapril
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 18
Study: 3197345

Group type: EXPERIMENTAL
Intervention: Older patients (66 years and older) with aneurysmal SAH
Number of subjects: 61

Group type: COMPARATOR
Intervention: Younger patients with aneurysmal SAH
Number of subjects: 61
Study: 29961572

Group type: EXPERIMENTAL
Intervention: Tocilizumab (280 mg intravenous infusion)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study: 28801444

Group type: EXPERIMENTAL
Intervention: Intravesical maintenance BCG (mBCG) immunotherapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Primary radical cystectomy (RC)
Number of subjects: 60
Study: 25552522

Group type: EXPERIMENTAL
Intervention: Discharge Liaison-Team in cooperation with a dietician
Number of subjects: 71

Group type: COMPARATOR
Intervention: Discharge Liaison-Team
Number of subjects: 71
Study: 23463301

Group type: EXPERIMENTAL
Intervention: Tränkmann's bite-jumping appliances
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 69
Study: 21576829

Group type: EXPERIMENTAL
Intervention: Valsartan (40-80 mg)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Non-ARB treatment
Number of subjects: 191
Study: 19225814

Group type: EXPERIMENTAL
Intervention: RelyX Unicem
Number of subjects: 32

Group type: COMPARATOR
Intervention: Panavia F 2.0
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Maxcem
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Multilink Sprint
Number of subjects: 32
Study: 16786354

Group type: EXPERIMENTAL
Intervention: Resistive vibration exercise (RVE)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 18
Study: 15385012

Group type: EXPERIMENTAL
Intervention: 1.25 mg x kg(‐1) 0.5% levobupivacaine
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 1 mg x kg(‐1) levobupivacaine
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 0.75 mg x kg(‐1) levobupivacaine
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 0.5 mg x kg(‐1) levobupivacaine
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Mean duration of lower limb motor blockade
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Motor block MLAD
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: ED50
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: ED95
Number of subjects: 50
Study: 11203270

Group type: EXPERIMENTAL
Intervention: Mini-tablets (filled into hard gelatin capsules)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Commercial matrix formulation (Ibu-Slow 600)
Number of subjects: 8
Study: 9363358

Group type: EXPERIMENTAL
Intervention: Odor thresholds measured at 04:00 h and 16:00 h
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Trigeminal pain thresholds measured at 04:00 h and 16:00 h
Number of subjects: 5
Study: 1778222

Group type: EXPERIMENTAL
Intervention: Atropine infusion
Number of subjects: 21

Group type: COMPARATOR
Intervention: Continuous intravenous glucose infusion [44.4 mumol kg‐1 body weight (bw) min‐1]
Number of subjects: 21
Study: 7130741

Group type: EXPERIMENTAL
Intervention: Investigational liquid formula of 8-methoxypsoralen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional crystalline 8-methoxypsoralen
Number of subjects: 0
Study: 30817696

Group type: EXPERIMENTAL
Intervention: Sleep Deprivation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Well Rested
Number of subjects: 20
Study: 28414806

Group type: EXPERIMENTAL
Intervention: Nurse-led multifactorial care (comprehensive geriatric assessment and tailored interventions)
Number of subjects: 2283

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2283

Group type: EXPERIMENTAL
Intervention: Nurse-led multifactorial care
Number of subjects: 2283
Study: 27220987

Group type: EXPERIMENTAL
Intervention: Antenatal corticosteroids (ACS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no ACS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention clusters (ACS exposure)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ACS administration within 7 days of delivery
Number of subjects: 0